T1	Participants 292 337	patients with chronic immune thrombocytopenia
T2	Participants 437 581	adults with previously treated immune thrombocytopenia of more than 6 months' duration who had baseline platelet counts lower than 30,000 per Î¼L
T3	Participants 2786 2817	chronic immune thrombocytopenia
T4	Participants 2860 2929	patients who have not responded to splenectomy or previous treatment.
